Abstract

In summary, RHOA is a critical downstream effector of GNAQ in NKTCL. GNAQ promotes RHOA activation through ARHGEF25, which in turn regulates cellular functions by modulating cell proliferation and apoptosis, thereby influencing the progression of NKTCL.

Affiliated Institutions

Related Publications

The noncanonical NF‐κB pathway

Summary: The noncanonical nuclear factor‐κB (NF‐κB) signaling pathway mediates activation of the p52/RelB NF‐κB complex and, thereby, regulates specific immunological processes....

2012 Immunological Reviews 680 citations

Publication Info

Year
2025
Type
article
Volume
26
Issue
1
Pages
2598074-2598074
Citations
0
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

0
OpenAlex

Cite This

Yuyang Gao, Zihe Zhang, Wenting Song et al. (2025). GNAQ inhibits tumorigenesis via the ARHGEF25-mediated RHOA pathway in NK/T-cell lymphoma. Cancer Biology & Therapy , 26 (1) , 2598074-2598074. https://doi.org/10.1080/15384047.2025.2598074

Identifiers

DOI
10.1080/15384047.2025.2598074